Loading...
A novel approach to crystallisation of nanodispersible microparticles by spray drying for improved tabletability
Paluch, Krzysztof J. Tajber, L. Adamczyk, B. Corrigan, O.I. Healy, A.M.
Paluch, Krzysztof J.
Tajber, L.
Adamczyk, B.
Corrigan, O.I.
Healy, A.M.
Publication Date
2012-10-15
End of Embargo
Supervisor
Rights
© 2012 Elsevier. Reproduced in accordance with the publisher's selfarchiving
policy. This manuscript version is made available under the CC-BY-NC-ND 4.0 license.
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2012-05-30
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
High-dose API powders which are to be tableted by direct compression should have high compactibility and compressibility. This note reports on a novel approach to the manufacture of crystalline powders intended for direct compaction with improved compactibility and compressibility properties. The poorly compactable API, chlorothiazide, was spray dried from a water/acetone solvent mix producing additive-free nanocrystalline microparticles (NCMPs) of median particle size 3.5 μm. Tablets compacted from NCMPs had tensile strengths ranging from 0.5 to 4.6 MPa (compared to 0.6–0.9 MPa for tablets of micronised CTZ) at compression forces ranging from 6 kN to 13 kN. NCMP tablets also had high porosities (34–20%) and large specific surface areas (4.4–4.8 m2/g). The time taken for tablets made of NCMPs to erode was not statistically longer (p > 0.05) than for tablets made of micronised CTZ. Fragmentation of NCMPs on compression was observed. The volume fraction of particles below 1 μm present in the suspension recovered after erosion of NCMP tablets was 34.8 ± 3.43%, while no nanosized particles were detected in the slurry after erosion of compacted micronised CTZ.
Version
Accepted manuscript
Citation
Paluch KJ, Tajber L, Adamczyk B et al (2012) A novel approach to crystallisation of
nanodispersible microparticles by spray drying for improved tabletability. International Journal of
Pharmaceutics. 436(1-2): 873-876.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article